Litcius/Paper detail

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial

Hossein Kasiri, Nima Rouhani, Ebrahim Salehifar, Monireh Ghazaeian, Sahar Fallah

2021International Immunopharmacology52 citationsDOIOpen Access PDF

Topics & Concepts

Mometasone furoateAnosmiaMedicineNasal administrationHyposmiaClinical trialVisual analogue scaleRandomized controlled trialNasal sprayInternal medicineCoronavirus disease 2019 (COVID-19)CorticosteroidAnesthesiaPharmacologyDiseaseInfectious disease (medical specialty)Olfactory and Sensory Function StudiesEssential Oils and Antimicrobial ActivityAdvanced Chemical Sensor Technologies
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial | Litcius